Pharmaceutical

STAT+: How a key Senate committee is planning to regula...

A key Senate health care panel has developed a plan to tackle reforms to middlem...

After FDA nod, Better Therapeutics races to boost dwind...

In the latest edition of STAT's Health Tech newsletter: Better Therapeutics race...

Listen: Wegovy in the brain, pivotal Alzheimer’s data, ...

Is Wegovy really a brain drug? Which Alzheimer's disease treatment works best? A...

Celiac study examines precisely how gluten triggers inj...

A new study of celiac disease offers a possible explanation for how gluten can s...

J&J expands global access to TB drug as popular novelis...

Johnson & Johnson expanded global access to tuberculosis drug this week amid nov...

STAT+: Demand spikes in seniors, behavioral health care...

UnitedHealth Group’s provider arm struggled in the second quarter as more senior...

Atrial fibrillation market set to decline at a CAGR of ...

Atrial fibrillation drugs' patent expiration is largely responsible for the pred...

HTA outcomes in the 5EU are growing at 27% with a deep ...

GlobalData has analysed HTA decisions made for branded medicines in 5EU from 201...

Roche eyes alternate mode of administration for Ocrevus...

The investigation combines Ocrevus’ subcutaneous formulation with Halozyme’s dru...

Tenpoint raises funds to develop cell therapies for vis...

Tenpoint Therapeutics has raised Series A funds of $70m for developing engineere...

FDA accepts BeiGene’s sNDA for follicular lymphoma therapy

The US FDA has accepted for review BeiGene’s sNDA for Brukinsa plus obinutuzumab...

ICR to enter AI-powered cancer drug discovery partnership

Scientists at the ICR, London are set to enter a partnership to merge capabiliti...

FDA greenlights first over-the-counter birth control pill

The non-age-restricted pill is expected to roll out early in 2024, and will ‘low...

Actimed plans trials to treat muscle wasting syndrome i...

The company aims to start two trials in H1 2024 based on its current timeline, d...

NVIDIA invests $50m in AI-enabled drug discovery

NVIDIA signed an investment and collaboration agreement with Recursion to create...

Aridis’s AR-301 monoclonal antibody to receive FDA QIDP...

US FDA granted the IgG1 monoclonal antibody the first qualified infectious disea...